Tempo Therapeutics Overview

  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $3.84M
Latest Deal Amount
  • Investors
  • 2

Tempo Therapeutics General Information

Description

Developer of a injectable hydro gel created to administer regenerative tissue treatments. The company's hydro gel uses cell-free synthetic materials that use geometric technology to unlock the body's own regenerative capacity and control inflammation, enabling patients to achieve accelerated healing rates, reduced chronic tissue inflammation and increased regenerative healing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 3030 Bunker Hill Street
  • Suite 104
  • San Diego, CA 92109
  • United States
+1 (251) 000-0000

Tempo Therapeutics Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tempo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 01-Jun-2020 $3.84M 00.000 Completed Generating Revenue
3. Grant 15-Sep-2019 00000 00000 Completed Generating Revenue
2. Angel (individual) Cancelled Startup
1. Angel (individual) $500K $500K Completed Startup
To view Tempo Therapeutics’s complete valuation and funding history, request access »

Tempo Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Westbrook Weaver Ph.D Co-Founder, Chief Executive Officer, President, Director & Board Member
Donald Griffin Ph.D Co-Founder, CSO, Director & Board Member
Philip Scumpia Ph.D Co-Founder & Clinical Advisor
Dino Di Carlo Ph.D Co-Founder & Board of Director
To view Tempo Therapeutics’s complete executive team members history, request access »

Tempo Therapeutics Board Members (5)

Name Representing Role Since
Dino Di Carlo Ph.D Self Co-Founder & Board of Director 000 0000
Donald Griffin Ph.D Tempo Therapeutics Co-Founder, CSO, Director & Board Member 000 0000
Richard Hancock Tempo Therapeutics Board of Director 000 0000
Steven Richieri Tempo Therapeutics Board of Director 000 0000
Westbrook Weaver Ph.D Tempo Therapeutics Co-Founder, Chief Executive Officer, President, Director & Board Member 000 0000
To view Tempo Therapeutics’s complete board members history, request access »

Tempo Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Tempo Therapeutics’s complete investors history, request access »